These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 33713279)

  • 21. Does sacral neuromodulation lead to relevant reduction in the need for intermittent catheterization? A single-center experience on patients with chronic urinary retention.
    Denzinger S; Nowrotek A; Weingart P; Burger M; Wieland WF; Rößler W; Otto W
    Neuromodulation; 2012; 15(6):586-91; discussion 591. PubMed ID: 22672285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective, multicenter study of a novel, miniaturized rechargeable sacral neuromodulation system: 12-month results from the RELAX-OAB study.
    Blok B; Van Kerrebroeck P; de Wachter S; Ruffion A; Van der Aa F; Jairam R; Perrouin-Verbe MA; Elneil S
    Neurourol Urodyn; 2019 Feb; 38(2):689-695. PubMed ID: 30592526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medium-term outcomes of sacral neuromodulation in patients with refractory overactive bladder: A retrospective single-institution study.
    Kaaki B; Gupta D
    PLoS One; 2020; 15(7):e0235961. PubMed ID: 32645082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients with Sacral Neuromodulation: What Are the Factors Affecting Their Therapy Satisfaction?
    Banakhar M; Hassouna M
    Urol Int; 2019; 103(4):450-453. PubMed ID: 31574517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementation of sacral neuromodulation for urinary indications. A Danish prospective study during the initial 15 months of a new service in a tertiary referral hospital.
    Kobberø H; Andersen M; Andersen K; Pedersen TB; Poulsen MH
    Scand J Urol; 2022; 56(5-6):404-411. PubMed ID: 36085579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effectiveness and safety of sacral neuromodulation on neurogenic bladder and bowel dysfunction in patients with spina bifida].
    Chen G; Wang Y; Ying X; Pang D; Liao L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2021 Nov; 35(11):1374-1379. PubMed ID: 34779161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sacral Neuromodulation with the InterStim™ System for Intractable Lower Urinary Tract Dysfunctions (SOUNDS): Results of Clinical Effectiveness, Quality of Life, Patient-Reported Outcomes and Safety in a French Multicenter Observational Study.
    Chartier-Kastler E; Le Normand L; Ruffion A; Dargent F; Braguet R; Saussine C; Tanneau Y; Graziana JP; Ragni E; Rabut B; Rousseau T; Biardeau X; Gamé X; Pierrevelcin J; Brassart E; Fourmarier M; Stoica G; Berrogain N; Yaghi N; Pecoux F; Capon G; Ferchaud J; Peyrat L; Bryckaert PE; Karsenty G; Melotti A; Abouihia A; Keller DUJ; Cornu JN
    Eur Urol Focus; 2021 Nov; 7(6):1430-1437. PubMed ID: 32907782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sacral Neuromodulation for Lower Urinary Tract and Bowel Dysfunction in Animal Models: A Systematic Review With Focus on Stimulation Parameter Selection.
    Douven P; Assmann R; Breukink SO; Melenhorst J; Kleijnen J; Joosten EA; van Koeveringe GA
    Neuromodulation; 2020 Dec; 23(8):1094-1107. PubMed ID: 32809262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sacral neuromodulation treatment for urinary voiding dysfunctions: results of treatment with the largest single-center series in a tertiary referral center in Turkey.
    Kütükoğlu MU; Altuntaş T; Şahin B; Onur AR
    Turk J Med Sci; 2023 Feb; 53(1):206-210. PubMed ID: 36945940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuromodulation for Storage Lower Urinary Tract Symptoms in Parkinson Disease: A Systematic Review.
    Smith MD; Tenison E; Hashim H; Ben-Shlomo Y; Henderson EJ
    Neuromodulation; 2022 Dec; 25(8):1076-1085. PubMed ID: 35300922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Safety of Sacral and Percutaneous Tibial Neuromodulation in Non-neurogenic Lower Urinary Tract Dysfunction and Chronic Pelvic Pain: A Systematic Review of the Literature.
    Tutolo M; Ammirati E; Heesakkers J; Kessler TM; Peters KM; Rashid T; Sievert KD; Spinelli M; Novara G; Van der Aa F; De Ridder D
    Eur Urol; 2018 Mar; 73(3):406-418. PubMed ID: 29336927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of sacral neuromodulation and percutaneous tibial nerve stimulation in the treatment of chronic nonobstructive urinary retention: A systematic review.
    Ho FCS; He C; Yao HH; O'Connell HE; Gani J
    Neurourol Urodyn; 2021 Jun; 40(5):1078-1088. PubMed ID: 33973670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of sacral neuromodulation on pudendal nerve function and female sexual function.
    Parnell BA; Howard JF; Geller EJ
    Neurourol Urodyn; 2015 Jun; 34(5):456-60. PubMed ID: 24615871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sacral neuromodulation for female pelvic floor disorders.
    El-Azab AS; Siegel SW
    Arab J Urol; 2019 Mar; 17(1):14-22. PubMed ID: 31258941
    [No Abstract]   [Full Text] [Related]  

  • 35. Pediatric sacral nerve stimulator explanation due to complications or cure: a survival analysis.
    Rensing AJ; Szymanski KM; Dunn S; King S; Cain MP; Whittam BM
    J Pediatr Urol; 2019 Feb; 15(1):39.e1-39.e6. PubMed ID: 30473473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive impairment does not impact sacral neuromodulation implant rates for overactive bladder.
    Zillioux J; Lewis KC; Hettel D; Goldman HB; Vasavada SP; Gill BC
    Neurourol Urodyn; 2023 Mar; 42(3):623-630. PubMed ID: 36701189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sacral neuromodulation and sexual function: a systematic review and meta-analysis of the literature.
    Khunda A; McCormick C; Ballard P
    Int Urogynecol J; 2019 Mar; 30(3):339-352. PubMed ID: 30535791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tibial Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review.
    Schneider MP; Gross T; Bachmann LM; Blok BF; Castro-Diaz D; Del Popolo G; Groen J; Hamid R; Karsenty G; Pannek J; Hoen L'; Kessler TM
    Eur Urol; 2015 Nov; 68(5):859-67. PubMed ID: 26194043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sacral neuromodulation for lower urinary tract dysfunction.
    Van Kerrebroeck PE; Marcelissen TA
    World J Urol; 2012 Aug; 30(4):445-50. PubMed ID: 21989816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment for refractory overactive bladder: a systematic review and meta-analysis of sacral neuromodulation and onabotulinumtoxinA.
    He Q; Li B; Zhang C; Zhang J; Luo D; Wang K
    Int Urogynecol J; 2021 Mar; 32(3):477-484. PubMed ID: 32661556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.